Patents by Inventor Georgina Meneses-Lorente

Georgina Meneses-Lorente has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosages
    Publication number: 20230340110
    Abstract: The present invention relates to a treatment regime, including an antibody or antigen-binding fragment which is capable of binding specifically to colony stimulating factor-1 receptor (CSF-1R) for use in the treatment of tenosynovial giant cell tumour (TGCT) in a subject, as well as associated uses and methods.
    Type: Application
    Filed: November 1, 2022
    Publication date: October 26, 2023
    Applicant: Synox Therapeutics UK Limited
    Inventors: Axel Mescheder, Raymond Barlow, Michael Cannarile, Georgina Meneses-Lorente
  • METHODS OF TREATING CANCER
    Publication number: 20220257592
    Abstract: Provided herein are methods of treating cancer in a patient in need thereof includes administering to the patient a therapeutically effective amount of entrectinib wherein the patient has impaired hepatic function and methods of managing adverse reactions of administration of entrectinib in a patient.
    Type: Application
    Filed: February 1, 2022
    Publication date: August 18, 2022
    Applicants: HOFFMANN-LA ROCHE INC., IGNYTA, INC., GENENTECH, INC.
    Inventors: Georgina Meneses-Lorente, Edna Chow Maneval, Pratik S. Multani, Susan Diane Eng, Sergio Rene Ley Acosta